Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows (Unaudited)

v3.24.0.1
Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Reconciliation of net loss to net cash used in operating activities:    
Net loss $ (3,290) $ (2,354)
Stock option compensation to employees and directors 1,108 957
Stock options issued to consultants 56 81
Common stock issued to consultants 96 25
Amortization of operating lease right-to-use asset 13 11
Change in operating assets and liabilities:    
Receivables (121) (100)
Prepaid expenses and other current assets 212 210
Accounts payable 158 (155)
Accrued expenses (528) (651)
Operating lease liability (13) (12)
Net cash used in operating activities (2,309) (1,988)
Cash flows from investing activities:    
Disbursements to acquire short-term investments (20,020) (7,835)
Proceeds from maturities of short-term investments 20,149 7,250
Net cash provided by (used in) investing activities 129 (585)
Cash flows from financing activities:    
Net proceeds from sale of common stock in an at-the-market offering 2,196
Proceeds from exercise of stock options 67 3
Net cash provided by financing activities 2,263 3
Net increase (decrease) in cash and cash equivalents 83 (2,570)
Cash and cash equivalents at beginning of period 915 12,360
Cash and cash equivalents at end of period $ 998 $ 9,790